BackChongqing Pharscin Pharmaceutical , Ltd. Overview

Chongqing Pharscin Pharmaceutical , Ltd. Receivables

Latest receivables for 002907.SZ: $400M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$396.31M
↑ 37.89% YoYΔ $108.90M vs prior year quarter

Peer trimmed avg / median

Loading

Chongqing Pharscin Pharmaceutical , Ltd. Receivables History

Loading

Chongqing Pharscin Pharmaceutical , Ltd. vs. peers: Receivables Comparison

Loading

Chongqing Pharscin Pharmaceutical , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chongqing Pharscin Pharmaceutical , Ltd. (002907.SZ) FAQ

The latest receivables for 002907.SZ is $400M as of September 2026. That compares with $290M in the prior-year period — up 37.9% year over year. Investors often review this figure alongside Chongqing Pharscin Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 002907.SZ's receivables moved from $290M to $400M — a 37.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chongqing Pharscin Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A receivables figure of $400M for 002907.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 002907.SZ's receivables ($400M), review year-over-year change from $290M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.